Lawrence (Larry) Lesko is a bioanalytical veteran with many years of academic and FDA experience. Now, as director of the University of Florida’s Center for Pharmacometrics and Systems Pharmacology, Larry uses metabolomics to discover biomarkers of drug toxicity.
Rich Whitworth |
sponsored by Agilent Technologies
Larry became a chemist at the age of seven with a Christmas gift that fired a growing interest in magic rocks, rockets and (by today’s standards) dangerous chemical reactions. At high school, Larry’s lifelong interest in pharmaceuticals began with a part-time job at the local pharmacy, where he was tasked with drug compounding – essentially, a continuation of his childhood chemistry set experience...
Read the full article now
Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Analytical Scientist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.